FDA: Sun Pharmaceutical recalls four lots of Vecuronium Bromide

Editor's Note

The Food & Drug Administration (FDA) on January 8 announced the recall by Sun Pharmaceutical Industries, Inc (Cranbury, New Jersey) of three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized powder) (Lots: JKS0443A, JKS0444A, JKS0477A), and one lot of Vecuronium Bromide for Injection, 20 mg (lyophilized powder) (Lot: JKS0400A),  because of the presence of particulate matter identified as glass.

Vecuronium Bromide is used as an adjunct to general anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

To date, Sun Pharmaceutical has not received any reports of adverse events related to this recall.